Skip Ribbon Commands
Skip to main content

NovaPure Components: The New Definition of High-Quality

In recent years, there has been a shift in the pharmaceutical industry toward a Quality by Design (QbD) philosophy. To maximize a drug product’s safety and efficacy, pharmaceutical companies and their drug packaging and delivery partners are building new quality principles into the entire manufacturing process, from design and development to commercialization and administration. This scientific, risk-based QbD approach is fast becoming an essential strategy for bringing high-quality therapeutics to market quickly and efficiently.

Through a product development process that incorporates QbD principles and puts the patient first, West has developed NovaPure® components to help ensure the efficacy and purity of a drug product. The NovaPure product offering includes serum and lyophilization stoppers and syringe plungers.

NovaPure components help pharmaceutical companies lower total cost of ownership through reduced compliance risk, reduced filling rejection rate, and reduced process costs.

NovaPure components are configured in key vial stopper and plunger designs and incorporate high quality processes and features, including: FluroTec Barrier Film, validated wash and sterilization processes, 100% vision verification and a comprehensive extractables profile.




NovaPure and FluroTec are trademarks or registered trademarks of West Pharmaceutical Services, Inc., in the United States and other jurisdictions. FluroTec® technology is licensed from Daikyo Seiko, Ltd.